NCT02253862View on ClinicalTrials.gov

Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2006

Conditions
Healthy
Interventions
DRUG

Tadalafil

administered days 1, 8 and 16

DRUG

Tipranavir

administered days 8-18

DRUG

Ritonavir

administered days 8-18

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY